Elevated Level of Circulating Platelet-derived Microparticles in Oral Cancer

Journal of Dental Research

Volumn 95, Issue 1, 2016, Pages 87-93

  Ren, J G ^a   Man, Q W ^a   Zhang, W ^a   Li, C ^a   Xiong, X P ^a   Zhu, J Y ^a   Wang, W M ^a   Sun, Z J ^a   Jia, J ^a   Zhang, W F ^a   Zhao, Y F ^a   Chen, G ^a   Liu, B ^a  

^a WUHAN UNIVERSITY   (China)

Author keywords

blood coagulation; blood platelets; cell derived microparticles; flow cytometry; inflammation; mouth neoplasms

Indexed keywords

CYTOKINE; FIBRINOGEN; IL6 PROTEIN, HUMAN; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

BLOOD; BLOOD CLOTTING; CANCER STAGING; CHEMISTRY; COMPARATIVE STUDY; FEMALE; FLOW CYTOMETRY; HUMAN; MALE; MEMBRANE MICROPARTICLE; MOUTH TUMOR; ODONTOGENIC TUMOR; PATHOLOGY; PHYSIOLOGY; PROCEDURES; SQUAMOUS CELL CARCINOMA; THROMBOCYTE;

BLOOD COAGULATION; BLOOD PLATELETS; CARCINOMA, SQUAMOUS CELL; CELL-DERIVED MICROPARTICLES; CYTOKINES; FEMALE; FIBRINOGEN; FLOW CYTOMETRY; HUMANS; INTERLEUKIN-6; MALE; MOUTH NEOPLASMS; NEOPLASM STAGING; ODONTOGENIC TUMORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84951792725     PISSN: 00220345     EISSN: 15440591     Source Type: Journal    
DOI: 10.1177/0022034515592593     Document Type: Article

References (38)

1. Amabile N, Guerin AP, Leroyer A, Mallat Z, Nguyen C, Boddaert J, London GM, Tedgui A, Boulanger CM,. 2005. Circulating endothelial microparticles are associated with vascular dysfunction in patients with end-stage renal failure. J Am Soc Nephrol. 16 (11): 3381-3388.
2. Andersson BA, Lewin F, Lundgren J, Nilsson M, Rutqvist LE, Lofgren S, Laytragoon-Lewin N,. 2014. Plasma tumor necrosis factor-alpha and C-reactive protein as biomarker for survival in head and neck squamous cell carcinoma. J Cancer Res Clin Oncol. 140 (3): 515-519.
3. Bagan J, Sarrion G, Jimenez Y,. 2010. Oral cancer: clinical features. Oral Oncol. 46 (6): 414-417.
4. Barnes L, Eveson JW, Reichart P, Sidransky D,. 2005. World Health Organization classification of tumours: pathology and genetics of head and neck tumours. Lyon (France): IARC Press.
5. Chironi GN, Boulanger CM, Simon A, Dignat-George F, Freyssinet JM, Tedgui A,. 2009. Endothelial microparticles in diseases. Cell Tissue Res. 335 (1): 143-151.
6. Cui Y, Zheng L, Jiang M, Jia R, Zhang X, Quan Q, Du G, Shen D, Zhao X, Sun W, et al. 2013. Circulating microparticles in patients with coronary heart disease and its correlation with interleukin-6 and C-reactive protein. Mol Biol Rep. 40 (11): 6437-6442.
7. Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A,. 2010. AJCC cancer staging manual. 7th ed. New York (NY): Springer.
8. Fleitas T, Martinez-Sales V, Vila V, Reganon E, Mesado D, Martin M, Gomez-Codina J, Montalar J, Reynes G,. 2012. Circulating endothelial cells and microparticles as prognostic markers in advanced non-small cell lung cancer. PLoS One. 7 (10): e47365.
9. Geddings JE, Mackman N,. 2013. Tumor-derived tissue factor-positive microparticles and venous thrombosis in cancer patients. Blood. 122 (11): 1873-1880.
10. Go SI, Lee A, Lee US, Choi HJ, Kang MH, Kang JH, Jeon KN, Park MJ, Kim SH, Lee GW,. 2014. Clinical significance of the neutrophil-lymphocyte ratio in venous thromboembolism patients with lung cancer. Lung Cancer. 84 (1): 79-85.
11. Herring JM, McMichael MA, Smith SA,. 2013. Microparticles in health and disease. J Vet Intern Med. 27 (5): 1020-1033.
12. Jansen F, Yang X, Hoyer FF, Paul K, Heiermann N, Becher MU, Abu Hussein N, Kebschull M, Bedorf J, Franklin BS, et al. 2012. Endothelial microparticle uptake in target cells is annexin I/phosphatidylserine receptor dependent and prevents apoptosis. Arterioscler Thromb Vasc Biol. 32 (8): 1925-1935.
13. Jansen F, Yang X, Hoelscher M, Cattelan A, Schmitz T, Proebsting S, Wenzel D, Vosen S, Franklin BS, Fleischmann BK, et al. 2013. Endothelial microparticle-mediated transfer of MicroRNA-126 promotes vascular endothelial cell repair via SPRED1 and is abrogated in glucose-damaged endothelial microparticles. Circulation. 128 (18): 2026-2038.
14. Kakkar AK, Macbeth F,. 2010. Antithrombotic therapy and survival in patients with malignant disease. Br J Cancer. 102 (1): 24S-29S.
15. Kerr R, Stirling D, Ludlam CA,. 2001. Interleukin 6 and haemostasis. Br J Haematol. 115 (1): 3-12.
16. Kim HK, Song KS, Park YS, Kang YH, Lee YJ, Lee KR, Ryu KW, Bae JM, Kim S,. 2003. Elevated levels of circulating platelet microparticles, VEGF, IL-6 and RANTES in patients with gastric cancer: possible role of a metastasis predictor. Eur J Cancer. 39 (2): 184-191.
17. Laresche C, Pelletier F, Garnache-Ottou F, Lihoreau T, Biichle S, Mourey G, Saas P, Humbert P, Seilles E, Aubin F,. 2014. Increased levels of circulating microparticles are associated with increased procoagulant activity in patients with cutaneous malignant melanoma. J Invest Dermatol. 134 (1): 176-182.
18. Lee LA, Huang CG, Liao CT, Lee LY, Hsueh C, Chen TC, Lin CY, Fan KH, Wang HM, Huang SF, et al. 2012. Human papillomavirus-16 infection in advanced oral cavity cancer patients is related to an increased risk of distant metastases and poor survival. PLoS One. 7 (7): e40767.
19. Li C, Zhao Y, Zhang W,. 2011. Increased prevalence of T(H)17 cells in the peripheral blood of patients with head and neck squamous cell carcinoma. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 112 (1): 81-89.
20. Lovren F, Verma S,. 2013. Evolving role of microparticles in the pathophysiology of endothelial dysfunction. Clin Chem. 59 (8): 1166-1174.
21. Mandala M, Falanga A, Roila F,. 2011. Management of venous thromboembolism (VTE) in cancer patients: ESMO clinical practice guidelines. Ann Oncol. 22 (6 Suppl): 85vi-92vi.
22. Mendes RA, Carvalho JF, van der Waal I,. 2010. Characterization and management of the keratocystic odontogenic tumor in relation to its histopathological and biological features. Oral Oncol. 46 (4): 219-225.
23. Morel O, Jesel L, Freyssinet JM, Toti F,. 2011. Cellular mechanisms underlying the formation of circulating microparticles. Arterioscler Thromb Vasc Biol. 31 (1): 15-26.
24. Nagy Z, Horvath O, Kadas J, Valtinyi D, Laszlo L, Kopper B, Blasko G,. 2012. D-dimer as a potential prognostic marker. Pathol Oncol Res. 18 (3): 669-674.
25. Noguti J, De Moura CF, De Jesus GP, Da Silva VH, Hossaka TA, Oshima CT, Ribeiro DA,. 2012. Metastasis from oral cancer: an overview. Cancer Genomics Proteomics. 9 (5): 329-335.
26. Parkin DM, Bray F, Ferlay J, Pisani P,. 2005. Global cancer statistics, 2002. CA Cancer J Clin. 55 (2): 74-108.
27. Periard D, Boulanger CM, Eyer S, Amabile N, Pugin P, Gerschheimer C, Hayoz D,. 2007. Are circulating endothelial-derived and platelet-derived microparticles a pathogenic factor in the cisplatin-induced stroke? Stroke. 38 (5): 1636-1638.
28. Principe S, Hui AB, Bruce J, Sinha A, Liu FF, Kislinger T,. 2013. Tumor-derived exosomes and microvesicles in head and neck cancer: implications for tumor biology and biomarker discovery. Proteomics. 13 (10-11): 1608-1623.
29. Reynes G, Vila V, Fleitas T, Reganon E, Font de, Mora J, Jorda M, Martinez-Sales V,. 2013. Circulating endothelial cells and procoagulant microparticles in patients with glioblastoma:prognostic value. PLoS One. 8 (7): e69034.
30. Suades R, Padro T, Vilahur G, Badimon L,. 2012. Circulating and platelet-derived microparticles in human blood enhance thrombosis on atherosclerotic plaques. Thromb Haemost. 108 (6): 1208-1219.
31. Tesse A, Martinez MC, Hugel B, Chalupsky K, Muller CD, Meziani F, Mitolo-Chieppa D, Freyssinet JM, Andriantsitohaina R,. 2005. Upregulation of proinflammatory proteins through NF-kappaB pathway by shed membrane microparticles results in vascular hyporeactivity. Arterioscler Thromb Vasc Biol. 25 (12): 2522-2527.
32. Thaler J, Ay C, Weinstabl H, Dunkler D, Simanek R, Vormittag R, Freyssinet JM, Zielinski C, Pabinger I,. 2011. Circulating procoagulant microparticles in cancer patients. Ann Hematol. 90 (4): 447-453.
33. Toth B, Nieuwland R, Liebhardt S, Ditsch N, Steinig K, Stieber P, Rank A, Gohring P, Thaler CJ, Friese K, et al. 2008. Circulating microparticles in breast cancer patients: a comparative analysis with established biomarkers. Anticancer Res. 28 (2A): 1107-1112.
34. Tseng CC, Wang CC, Chang HC, Tsai TH, Chang LT, Huang KT, Leu S, Yen CH, Liu SF, Chen CH, et al. 2013. Levels of circulating microparticles in lung cancer patients and possible prognostic value. Dis Markers. 35 (5): 301-310.
35. Varon D, Shai E,. 2009. Role of platelet-derived microparticles in angiogenesis and tumor progression. Discov Med. 8 (43): 237-241.
36. Warnakulasuriya S,. 2009. Global epidemiology of oral and oropharyngeal cancer. Oral Oncol. 45 (4-5): 309-316.
37. Wolf P,. 1967. The nature and significance of platelet products in human plasma. Br J Haematol. 13 (3): 269-288.
38. Zhang W, Sun YL, Chen DH,. 2014. Effects of chitin and sepia ink hybrid hemostatic sponge on the blood parameters of mice. Mar Drugs. 12 (4): 2269-2281.